Loading...
Market
What will be the outcome of the hostile takeover bid for Lykos Therapeutics by June 30, 2025?
3
Lykos Therapeutics•Antonio Gracias•Tesla•Gracias•Maps•Rick Doblin•Jeff Aronin•Paragon Biosciences•Lykos•FDA•Helena
Resolution / Starting Odds
Antonio Gracias acquires controlling stake • 25%
Helena vetoes the deal • 25%
Deal falls through for other reasons • 25%
Other outcome • 25%
Official announcements from Lykos Therapeutics or financial news outlets
Story
Antonio Gracias Leads Hostile Takeover Bid for MDMA Startup Lykos Therapeutics, Backed by $100 Million Funding and Rick Doblin
Jan 10, 2025, 05:38 AM
Lykos Therapeutics, a startup focused on MDMA-based therapies, is facing a hostile takeover bid led by Antonio Gracias, an early investor in Tesla. Gracias, who is allied with Maps founder Rick Doblin, aims to secure a controlling stake in the company with the support of Jeff Aronin, a prominent figure in the pharmaceutical industry and founder of Paragon Biosciences. The bid comes amid ongoing challenges for Lykos, including issues related to sexual abuse by therapists during clinical trials, which were highlighted during a recent FDA review. Additionally, Helena, which spearheaded Lykos's $100 million funding round last year, is reportedly seeking to sever ties between Lykos and the non-profit organization Maps, holding veto rights over any potential deal.
View original story
Similar markets
Modified Terms • 25%
Cancelled • 25%
Delayed • 25%
Completed • 25%
Talks Abandoned • 25%
Other Outcome • 25%
Ongoing Negotiations • 25%
Completed Sale • 25%
Accepted • 25%
Rejected • 25%
Counter-offer accepted • 25%
No decision • 25%
No • 50%
Yes • 50%
Additional Bitcoin purchase • 25%
No new investment • 25%
Partnership with another tech firm • 25%
New technology acquisition • 25%
Negotiations fail • 33%
Negotiations extended • 34%
Sale completed • 33%
No resolution • 25%
Takeover rejected • 25%
Successful takeover • 25%
Negotiated merger • 25%
Offer rejected • 25%
Offer modified • 25%
Other outcome • 25%
Successful acquisition • 25%
Cancelled • 25%
Fully subscribed • 25%
Partially subscribed • 25%
Not subscribed • 25%
Under-subscribed • 25%
Partially subscribed • 25%
Fully subscribed • 25%
Cancelled • 25%
Neutral • 25%
Unchanged • 25%
Positive • 25%
Negative • 25%